Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTt Electronics Regulatory News (TTG)

Share Price Information for Tt Electronics (TTG)

Share Price is delayed by 15 minutes
Get Live Data
116.40    0.80 (0.69%)
Bid:
116.20
Ask:
116.40
Spread: 0.20 (0.172%)
Market Cap: £207.63m
TTG Live PriceLast checked at - London Stock Exchange

Intraday Tt Electronics Share Chart

Form 8.3 - TT ELECTRONICS PLC

31 Oct 2025 14:49

RNS Number : 7524F
FIL Limited
31 October 2025
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

FMR LLC and/or one or more of its direct or indirect subsidiaries

And

FIL Limited and/or one or more of its direct and indirect subsidiaries

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor, and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

TT ELECTRONICS PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

30-October-2025

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

CICOR TECHNOLOGIES LTD.

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

25p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

21,890,919

12.29%

(2) Cash-settled derivatives:

8,465,151

4.75%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

30,356,070

17.04%

 

All interests and all short positions should be disclosed

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

Number of securities

Price per unit

25p ordinary

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

25p ordinary

CFD

Reducing a long position

4,996,445

0.95 USD/Unit

25p ordinary

CFD

Increasing a long position

4,996,445

0.95 USD/Unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None.

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None.

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

No

 

 

Date of disclosure:

31-October-2025

Contact name:

Aaron Watson

Telephone number:

00 353 1 223 1050

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETMBBITMTIJBPA
Date   Source Headline
28th Apr 20226:05 pmRNSDirector/PDMR Shareholding
27th Apr 20225:20 pmRNSDirector/PDMR Shareholding
27th Apr 202211:22 amRNSHolding(s) in Company
6th Apr 20224:15 pmRNSAnnual Financial Report
17th Mar 20227:00 amRNSDirector/PDMR Shareholding
16th Mar 20224:16 pmRNSDirector/PDMR Shareholding
15th Mar 202211:29 amRNSDirector Declaration
14th Mar 20223:00 pmRNSDirector/PDMR Shareholding
14th Mar 20223:00 pmRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSFull Year Results
1st Mar 20223:35 pmRNSTotal Voting Rights
2nd Feb 20224:30 pmRNSHolding(s) in Company
1st Feb 20223:05 pmRNSTotal Voting Rights
10th Jan 20227:00 amRNSAcquisition of Ferranti Power & Control business
4th Jan 20222:20 pmRNSTotal Voting Rights
22nd Dec 202110:07 amRNSHolding(s) in Company
15th Dec 20214:00 pmRNSHolding(s) in Company
1st Dec 20213:06 pmRNSTotal Voting Rights
23rd Nov 20217:00 amRNSTrading Update
1st Nov 20215:05 pmRNSBlock Listing Six Monthly Return
1st Nov 20214:56 pmRNSDirector/PDMR Shareholding
30th Sep 20219:40 amRNSDirector/PDMR Shareholding
1st Sep 20211:30 pmRNSTotal Voting Rights
5th Aug 20217:00 amRNSHalf-year Results
2nd Aug 20213:38 pmRNSTotal Voting Rights
2nd Jul 20215:10 pmRNSTotal Voting Rights
16th Jun 20211:32 pmRNSUpdate on 2021 LTIP Award Targets
14th Jun 202110:16 amRNSHolding(s) in Company
1st Jun 20218:11 amRNSTotal Voting Rights
13th May 20211:19 pmRNSResult of AGM
13th May 20217:00 amRNSAGM Trading Update
12th May 20214:39 pmRNSDirector/PDMR Shareholding
4th May 20213:00 pmRNSBlock listing Interim Review
4th May 202110:42 amRNSTotal Voting Rights
1st Apr 20214:22 pmRNSTotal Voting Rights
1st Apr 202111:23 amRNSAnnual Report and AGM Arrangements
29th Mar 20218:05 amRNSHolding(s) in Company
26th Mar 20217:00 amRNSVirolens® registration received in Great Britain
25th Mar 202112:11 pmRNSUpdate on Virolens
19th Mar 202112:11 pmRNSDirector/PDMR Shareholding
18th Mar 20213:18 pmRNSHolding(s) in Company
16th Mar 20213:50 pmRNSDirector/PDMR Shareholding
16th Mar 20213:49 pmRNSDirector/PDMR Shareholding
10th Mar 202112:40 pmRNSHolding(s) in Company
10th Mar 20217:00 amRNSFull Year Results
1st Mar 202112:30 pmRNSTotal Voting Rights
8th Feb 20216:20 pmRNSHolding(s) in Company
1st Feb 202111:36 amRNSTotal Voting Rights
20th Jan 20214:55 pmRNSHolding(s) in Company
19th Jan 20213:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.